Visceral fat is the fat that accumulates around internal organs. It is metabolically distinct from subcutaneous fat: it is more inflammatory, more closely linked to insulin resistance, and more resistant to conventional diet and exercise than the fat you can see or pinch. For many patients, visceral fat accumulation that begins in middle age is one of the most stubborn and health-significant changes they experience, and one of the most inadequately addressed by standard interventions.
SUBHEADING: Tesamorelin is a GHRH analog that stimulates the pituitary to produce growth hormone, with a documented effect on visceral fat reduction and body composition. At AgeRejuvenation, it is evaluated and supervised by our physician-led team. CTAs (above-fold): [Book Your Consultation] [Call (813) 254-6141]
Visceral fat is the fat that accumulates around internal organs. It is metabolically distinct from subcutaneous fat: it is more inflammatory, more closely linked to insulin resistance, and more resistant to conventional diet and exercise than the fat you can see or pinch. For many patients, visceral fat accumulation that begins in middle age is one of the most stubborn and health-significant changes they experience, and one of the most inadequately addressed by standard interventions.
Tesamorelin is a growth hormone-releasing hormone (GHRH) analog. It stimulates the pituitary gland to produce more growth hormone, which in turn drives IGF-1 production from the liver, and that increased IGF-1 has a well-documented effect on reducing visceral adipose tissue. Tesamorelin works upstream: rather than attempting to target fat directly, it reactivates the hormonal cascade that normally keeps visceral fat under control. At AgeRejuvenation in Tampa, tesamorelin is offered as part of our physician-supervised peptide therapy program in Tampa, evaluated through a full hormonal and metabolic workup before any protocol is built.
What Is Tesamorelin?
Answer: Tesamorelin is a synthetic GHRH analog that stimulates the anterior pituitary to release growth hormone, triggering the downstream GH-IGF-1 axis. It has been studied in clinical settings specifically for visceral fat reduction and has also shown potential effects on cognitive function in older adults. Unlike direct HGH, tesamorelin works through the body's own pituitary pathway, preserving natural feedback controls.
The mechanism follows a clear cascade. Tesamorelin binds to GHRH receptors in the pituitary gland, prompting an increase in growth hormone secretion. That growth hormone travels to the liver and stimulates production of IGF-1. Elevated IGF-1 then acts on adipose tissue, fat cells, and metabolic processes throughout the body. The visceral fat reduction effect is one of the most studied outcomes of this cascade. The body's own feedback loop remains intact, meaning that when growth hormone reaches an appropriate level, the pituitary's GHRH response is modulated, preventing the runaway elevation that direct synthetic HGH can produce.
Tesamorelin's cognitive function findings are a separate area of emerging interest. Research published in peer-reviewed journals has suggested that the GH-IGF-1 axis plays a role in cognitive maintenance in older adults, and that supporting it through GHRH stimulation may have memory and processing speed benefits. These effects are distinct from the body composition outcomes and are evaluated separately in our clinical assessments. Schedule your evaluation today.
Conditions Tesamorelin Can Help Address
Tesamorelin addresses the hormonal axis that governs both body composition and metabolic health. Here is where it fits. The central therapeutic indication is reduction of visceral adipose tissue, the metabolically active fat around internal organs that correlates with cardiovascular and metabolic risk. Tesamorelin's GH-IGF-1 stimulation targets this tissue specifically, complementing weight loss and body composition services. Like sermorelin, tesamorelin addresses the age-related decline in pituitary growth hormone output. The downstream effects include lean muscle maintenance, fat distribution normalization, improved bone density, and better recovery. IGF-1 is increasingly recognized as a neuroprotective factor, and growth hormone decline in older adults correlates with some aspects of cognitive aging. Tesamorelin's support of the GH-IGF-1 axis is an area of ongoing investigation for its potential cognitive maintenance effects. Visceral fat is closely linked to insulin resistance and metabolic syndrome. By reducing visceral adipose tissue and supporting the GH-IGF-1 axis, tesamorelin contributes to the broader metabolic health improvements that are central to our wellness and metabolic program.
Advantages of Tesamorelin at AgeRejuvenation
Tesamorelin combines a pituitary-sparing mechanism with documented visceral fat effects. Here is how we implement it. Tesamorelin, like sermorelin, works through the pituitary's own GHRH pathway rather than introducing synthetic HGH directly. That means the body's feedback loop remains active. When GH reaches appropriate levels, the system self-moderates. This is a meaningful safety advantage over direct HGH administration. We measure IGF-1 before you start and at intervals through the protocol. That data confirms the pituitary is responding and guides dose adjustments. A tesamorelin protocol without monitoring is guesswork; ours is data-driven. Most approaches to visceral fat rely on caloric restriction or exercise. Tesamorelin addresses the hormonal environment that controls where the body stores fat in the first place. For patients who have reduced overall body fat through lifestyle changes but still carry visceral fat, tesamorelin addresses the upstream driver.
Why Choose AgeRejuvenation for Tesamorelin?
Our Tampa clinical team evaluates tesamorelin in the context of a complete hormonal picture. Growth hormone, IGF-1, thyroid, testosterone, and metabolic markers all interact. We do not prescribe tesamorelin without a baseline that tells us what your system is actually doing. Dr. Dawn Ericsson, MD, leads our clinical direction. Tesamorelin is part of the complete supervised peptide therapy program at AgeRejuvenation Tampa, where every protocol is built on individual lab data and reviewed at regular intervals. Book your evaluation today.
Tesamorelin is one of the growth hormone-supporting peptides within our supervised peptide therapy program at AgeRejuvenation Tampa, which also includes sermorelin, CJC-1295, and other individually evaluated options supervised by our physician-led team.
Explore more in our wellness center services .
